BNTX
Biontech Se Earnings
$89.97
Earnings Summary
Revenue | $898.89Mn |
Net Profits | $-302.14Mn |
Net Profit Margins | -33.61% |
Biontech Se’s revenue fell -24.46% since last year same period to $898.89Mn in the Q4 2025. On a quarterly growth basis, Biontech Se has generated -40.82% fall in its revenue since last 3-months.
Biontech Se’s net profit fell -216.43% since last year same period to $-302.14Mn in the Q4 2025. On a quarterly growth basis, Biontech Se has generated -952.75% fall in its net profits since last 3-months.
Biontech Se’s net profit margin fell -254.14% since last year same period to -33.61% in the Q4 2025. On a quarterly growth basis, Biontech Se has generated -1678.89% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -2.03 |
EPS Estimate Current Year | -2.03 |
Biontech Se’s earning per share (EPS) estimates for the current quarter stand at -2.03 - a -721.2% fall from last quarter’s estimates.
Biontech Se’s earning per share (EPS) estimates for the current year stand at -2.03.
Key Ratios
Earning Per Share (EPS) | 0 |
Biontech Se’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Biontech Se has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-11 | -2.03 | 0 | 100% |




